Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells

(2014) A. Seubert et al.   JOURNAL OF IMMUNOLOGY

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

(2013) Janet E McElhaney et al.   LANCET INFECTIOUS DISEASES

Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

(2012) Nathalie Garçon et al.   Expert Review of Vaccines

Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant

(2012) Murdo Ferguson et al.   JOURNAL OF INFECTIOUS DISEASES

Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V®and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderly

(2012) Roberto Gasparini et al.   Human Vaccines & Immunotherapeutics

Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study

(2011) Joanne M. Langley et al.   JOURNAL OF INFECTIOUS DISEASES

The safety evaluation of adjuvants during vaccine development: The AS04 experience

(2011) Nathalie Garçon et al.   VACCINE

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity

(2011) Sandra Morel et al.   VACCINE

AS03A‐Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age

(2010) François Roman et al.   CLINICAL INFECTIOUS DISEASES

MF59™ as a vaccine adjuvant: a review of safety and immunogenicity

(2010) Hana El Sahly   Expert Review of Vaccines

Mechanism of action of clinically approved adjuvants

(2009) Bart N Lambrecht et al.   CURRENT OPINION IN IMMUNOLOGY

Emulsion-based adjuvants for influenza vaccines

(2009) Frederick R Vogel et al.   Expert Review of Vaccines

Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response

(2009) Janet E McElhaney   Expert Review of Vaccines

Vaccine adjuvants: scientific challenges and strategic initiatives

(2009) Ali M Harandi et al.   Expert Review of Vaccines

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial

(2009) François Roman et al.   VACCINE

Better Influenza Vaccines for Older People: What Will It Take?

(2008) Janet E. McElhaney et al.   JOURNAL OF INFECTIOUS DISEASES

Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines

(2008) Thomas Verstraeten et al.   VACCINE

Correlates of protection: Novel generations of influenza vaccines

(2008) Guus F. Rimmelzwaan et al.   VACCINE